KKR launches Allyntra precision engineering platform
The firm is committing significant additional capital to fund acquisitions and has named Robbie Atkinson CEO of Allyntra, which will target medical technology and other high-precision end markets.
Takeaways
- Allyntra is a new precision engineering services platform serving medical technology and other high-precision end markets.
- KKR and Allyntra are classified as a platform transaction.
- The business serves medical technology and other high-precision industries.
Allyntra, a newly formed precision engineering solutions platform targeting medical technology and other high-precision end markets, has been launched by KKR.
The new company will serve customers in medical technology and adjacent high-precision industries that require complex engineering and technical services.
KKR plans to invest additional capital to support platform growth through acquisitions and organic expansion.
Robbie Atkinson has been appointed CEO of Allyntra, with Brian Highley serving as Chairman of the Board.
"As these technologies grow more sophisticated, customers are looking for partners that can help them move faster, solve increasingly complex challenges, and bring new ideas to life.
That is exactly the opportunity I see for Allyntra," said Robbie Atkinson, CEO of Allyntra.
Get tomorrow morning's tape in your inbox.
Yesterday's platforms, add-ons, recaps, and exits, cleaned up before the workday starts.